This is great news. But I am not convinced that it’s quite as significant as many are making out.
1. The news cycle at the moment is WILD. Yes it’s big news if you work in the industry and feels exciting, but outside of that it’s a story that lasts a few hours then vanishes.
2. Its success will depend on the end product, not just the fact it’s a big name. If they target an older aging population they will need wide variety of products and imo novel methods not flower.
3. Big corporations that enter the medical cannabis space are often guided by hyper merchants. They mean well to some extent but the prevailing message is one of how amazing the opportunity is rather than the quantity of the offer to patients.
4. The advertising restrictions make unlocking the 65+ demographic unbelievably challenging. It will take a whole lot more than Boots simply bring in the game.
Still great news, big win! But seen a few people on social media frame this as “biggest thing to happen in medical cannabis globally” 😬
https://t.co/eJZMHd40fO
Some further details patients may be interested in, we're still sourcing full product information:
- The @BootsUK Online Doctor service is run by @LemonaidHealth.
- MC prescriptions are handled via the @ScriptAssistUK platform.
- Allegedly, they're still preparing to launch fully, with several doctors in the pipeline that haven't been on-boarded yet.
- We are expecting just flower and oils at launch.
There's also reason to believe 5g flower packs may be available, £38 per 5g, £73 per 10g - though @MHRAgovuk has previously scalded companies for offering bulk discounts (due to incentivising purchasing more meds than may be required).
We'll have their formulary up as soon as possible ⌛️
Breaking: @lyphedispensary has launched the V range to UK patients.
Find out more about what that means for patients and the sector below 👇
https://t.co/5et9UqIkWT
Breaking: @lyphedispensary has launched the V range to UK patients.
Find out more about what that means for patients and the sector below 👇
https://t.co/5et9UqIkWT
Nice milestone for the new business - our first commercial filming job for the @UKCanCouncil at @Fieldfisher Law Firm.
Cracking event - speakers were spot on and enjoyed recording tons of vox pops with Holly.
Kamala Harris has taken a bold step, endorsing full cannabis legalisation.
She emphasised the need to stop criminalising cannabis use, particularly for marginalised communities disproportionately affected by drug laws.
Read more:
https://t.co/Ld5RBM1RkI
5/ The study calls for education, reform, and better access to NHS prescriptions to reduce inequality.
Full article and breakdown here:
https://t.co/QvKFokDzQ7
🧵1/ Cannabis has been legal for medical use in the UK since 2018, but patients still face stigma. A new study explores how prohibitionist attitudes persist. 👇
https://t.co/QvKFokDzQ7
8/ The rise in ketamine use demands action, not panic. Let’s ensure young people are empowered with the knowledge and support they need to make safer decisions. #DrugEducation#HarmReduction#Ketamine
https://t.co/raZz09Iu5u
🧵 Is Ketamine Use Among Young People in the UK a Growing Crisis?
1/ Recent data shows an increase in ketamine use among young people, but is it a crisis or a moderate rise? Let's dive into the stats and health impacts of this dissociative drug.
https://t.co/raZz09Iu5u
7/ Schools, universities, and harm reduction services must offer up-to-date, evidence-based education on ketamine’s risks, focusing on safer use and treatment options. Prevention starts with awareness! 🧠